Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LXEO is expected to report earnings to fall 8.08% to -91 cents per share on August 18

Lexeo Therapeutics LXEO Stock Earnings Reports

Q2'25

Est.

$-0.91

Q1'25

Missed

by $0.10

Q4'24

Missed

by $0.06

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.13

The last earnings report on May 13 showed earnings per share of -99 cents, missing the estimate of -88 cents. With 678.51K shares outstanding, the current market capitalization sits at 136.75M.

View a ticker or compare two or three

Compare

LXEO